Eli Lillys Zepbound, with the active ingredient tirzepatide, has been approved by the Food and Drug Administration for use by obese or overweight adults who have at least one weight-related health complication, like Type 2 diabetes, high blood pressure or high cholesterol
For patients without these high-risk comorbidities, metformin remains the foundational first-line therapy due to its long-standing evidence base, safety, and low cost
For adults and pediatric patients, subsequent dosages may be increased in case of an inadequate response in 25 to 50 mg per day increments once a week, depending on tolerability, up to a maximum of 200 mg per day
If you must self-inject here, consider using an injection aid device that holds the syringe at the correct angle while you operate the plunger with your free hand